US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

21.50

-0.0042-0.02%

Post-market: 21.500.0042+0.02%16:10 EDT

Volume:55

Turnover:1K

Market Cap:4.30M

PE:- -

High:21.50

Open:21.49

Low:21.50

Close:21.50

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.06

T/O Rate:0.03%

Dividend:0.08

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

Market Participants Report Indian Central Bank's Dollar Sales to Support Rupee

Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211

Global funds return to Indian stocks with US$1 bil in buying

Ashutosh Joshi / Bloomberg

India Ratings Upgrades Vadilal Industries’ Credit Profile to IND A+

Shanghai Henlius Biotech's Cancer Drug Combination Trial Gets IND Approval

MT Newswires Live

Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics

Shandong Boan Biotechnology's Cancer Drug Candidate Gets IND Acceptance; Shares Down 5%

MT Newswires Live

Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling

Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA

MT Newswires Live

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection

India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence

India's Stock Market Emerges as a Global Safe Haven Amid AI-Driven Volatility

India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence

India Ratings assigns and affirms IND BBB+ / A2 ratings to Foods & Inns bank facilities

Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance

Benzinga_recent_news

Edding Genor Receives NMPA Approval for Phase Ib/II Clinical Trial of GB268

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/IND/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":21.5,"timestamp":1790971200000,"preClose":21.5042,"halted":0,"volume":55,"hourTrading":{"tag":"盘后","latestPrice":21.5042,"preClose":21.5,"latestTime":"16:10 EDT","volume":8,"amount":172,"timestamp":1790971804806,"change":0.0042,"changeRate":0.000195,"amplitude":0},"delay":0,"changeRate":-0.00019531068349442759,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Market Closed","change":-0.0042,"latestTime":"10-02 16:00:00 EDT","open":21.49,"high":21.5,"low":21.5,"amount":1205,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":21.5042,"sharesOutstanding":200001,"nav":21.258,"aum":4251521.99,"dividendRate":0.003674,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.5042,"preClose":21.5,"latestTime":"16:10 EDT","volume":8,"amount":172,"timestamp":1790971804806,"change":0.0042,"changeRate":0.000195,"amplitude":0},"volumeRatio":0.06475158097165776},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.06475158097165776,"shares":200001,"dividePrice":0.079,"high":21.5,"amplitude":0,"preClose":21.5042,"low":21.5,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":21.5,"eps":0,"divideRate":0.003674,"volume":55,"delay":0,"ttmEps":0,"open":21.49,"prevYearClose":24.78,"prevWeekClose":22.3,"prevMonthClose":21.62,"prevQuarterClose":21.62,"fiveDayClose":22.3,"twentyDayClose":23.195,"sixtyDayClose":22.865},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651111171","title":"Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111171","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111171?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:01","pubTimestamp":1783944060,"startTime":"0","endTime":"0","summary":"- Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July  13, 2026  (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to levera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326162/36461/en/Voyager-Demonstrates-Single-IV-Dose-of-VY1706-Well-Tolerated-Reduced-Tau-in-6-Month-GLP-Toxicology-Study-Initiation-of-Clinical-Trial-in-Alzheimer-s-Disease-Expected-H2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4590","BBB","CNS","GDOC","GLP","NHP","BK4144","BK4110","IDNA","MEDX","AAIC","IND","HYLG","BK4225","BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133045648","title":"Market Participants Report Indian Central Bank's Dollar Sales to Support Rupee","url":"https://stock-news.laohu8.com/highlight/detail?id=1133045648","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133045648?lang=en_us&edition=fundamental","pubTime":"2026-07-13 12:50","pubTimestamp":1783918242,"startTime":"0","endTime":"0","summary":"According to multiple unnamed trading sources with knowledge of the matter, the Reserve Bank of India has been selling dollars in the onshore foreign exchange market to bolster the rupee's value. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPI","INDA","UUP","SMIN","IOPP","BK4588","SCIN","INCO","INDE","NFTY","NDIA","BK4585","BK4523","UDN","IND","FLIN","INQQ","IMVP","INDL","INDY","PIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651207161","title":"Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211","url":"https://stock-news.laohu8.com/highlight/detail?id=2651207161","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651207161?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:08","pubTimestamp":1783901304,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has issued an update. Abbisko Therapeutics has received clearance from the U.S. Food and Drug Administration ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-ind-clearance-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-ind-clearance-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IND","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146902","title":"Global funds return to Indian stocks with US$1 bil in buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146902","media":"Ashutosh Joshi / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146902?lang=en_us&edition=fundamental","pubTime":"2026-07-13 06:09","pubTimestamp":1783894143,"startTime":"0","endTime":"0","summary":"Foreign investors poured more than US$1 billion into Indian equities last week.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/india/global-funds-return-indian-stocks-us1-bil-buying?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/india/global-funds-return-indian-stocks-us1-bil-buying?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["INDY","BK4523","PIN","IND","EPI","SMIN","BK4585","INDA","NFTY","BK4588","FLIN","SCIN","INDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139262","title":"India Ratings Upgrades Vadilal Industries’ Credit Profile to IND A+","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139262","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139262?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:54","pubTimestamp":1783698887,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Vadilal Industries Limited ( ($IN:VADILALIND) ). India Ratings and Research has upgraded Vadilal Industries Lim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-vadilal-industries-credit-profile-to-ind-a?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-vadilal-industries-credit-profile-to-ind-a?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650518161","title":"Shanghai Henlius Biotech's Cancer Drug Combination Trial Gets IND Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2650518161","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650518161?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:12","pubTimestamp":1783678326,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (HKG:2696) said its investigational new drug application for a Phase I clinical trial of HLX37 in combination with chemotherapy or HLX43 has been approved by China's National ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND","HK0000306685.HKD","HK0000165453.HKD","HK0000320223.HKD","XBI","BK1161","HK0000306701.USD","02696","BK4581","BK4585","BK4588","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650922495","title":"Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2650922495","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650922495?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:16","pubTimestamp":1783602970,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that the FDA has cleared the company’s investigational new drug, or IND, application for QRX003 for the trea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-announces-fda-clearance-of-qrx003-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-announces-fda-clearance-of-qrx003-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588","BK4139","QNRX","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996159","title":"UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996159","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996159?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512000,"startTime":"0","endTime":"0","summary":"FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient enrollment expected to begin in Q4 2026UGN-501 is a different","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324037/0/en/UroGen-Announces-FDA-Clearance-of-the-IND-for-UGN-501-an-Investigational-Next-Generation-Oncolytic-Virus-for-Non-Muscle-Invasive-Bladder-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996156","title":"Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996156","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996156?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512000,"startTime":"0","endTime":"0","summary":"-- Arbitration tribunal declared that PM647 is within Prime Medicine’s “Field”, confirming Prime Medicine’s right to develop and commercialize PM647 in AATD --  -- Prime Medicine owes no monetary dama","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324031/0/en/Prime-Medicine-Announces-Positive-Resolution-to-Arbitration-with-Beam-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CTA","IND","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649968198","title":"Shandong Boan Biotechnology's Cancer Drug Candidate Gets IND Acceptance; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649968198","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649968198?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:16","pubTimestamp":1783491408,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co (HKG:6955) said its investigational new drug application for BA1203 has been accepted by China's Center for Drug Evaluation of the National Medical Products Administrati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06955","IND","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649987048","title":"Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling","url":"https://stock-news.laohu8.com/highlight/detail?id=2649987048","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649987048?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:30","pubTimestamp":1783427400,"startTime":"0","endTime":"0","summary":"Company also advances U.S. regulatory pathway for ONP-002 with FDA Type B meeting request All three Australian Phase IIa trial sites — Mackay Base Hospital, Alfred Health, and Royal Adelaide Hospital ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/07/3323198/0/en/Oragenics-Achieves-Full-Activation-of-Australian-Phase-IIa-Trial-Network-All-Three-Sites-Now-Enrolling.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4585","BK4139","LABU","BK4588","OGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649118606","title":"Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2649118606","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649118606?lang=en_us&edition=fundamental","pubTime":"2026-07-07 12:17","pubTimestamp":1783397876,"startTime":"0","endTime":"0","summary":"Celltrion  submitted an investigational new drug  amendment for a global Phase 3 trial of CT-P51, the biosimilar of its cancer drug Keytruda, to the U.S. Food & Drug Administration, according to a Monday filing with the Korea Exchange.The randomized, double-blind, active-controlled clinical trial will enroll 220 previously untreated patients who have metastatic non-squamous non-small cell lung cancer to compare the efficacy and safety of CT-P51 against the reference drug over a two-year treatment period, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK7095","IND.AU","IND","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649235026","title":"Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2649235026","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649235026?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:00","pubTimestamp":1783332000,"startTime":"0","endTime":"0","summary":"Key Points Immuron Engages Pullan Consulting to Advance IMM-529 Partnering StrategyImmuron is seeking a partner to support clinical development through regulatory approval and commercializationImmuron","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/06/3322259/37134/en/Immuron-Advances-IMM-529-Clostridioides-difficile-infection-Partnering-Strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SOC","BK4213","IMRN","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155756914","title":"ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1155756914","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155756914?lang=en_us&edition=fundamental","pubTime":"2026-07-06 08:10","pubTimestamp":1783296638,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced it recently submitted two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA).The applications are for a next-generation,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK4144","BK1191","BK4588","LABU","BK4585","BK1515","BK4160","JDOC","IND","BK4590","GIPR","GLP","BK1161","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183558958","title":"India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence","url":"https://stock-news.laohu8.com/highlight/detail?id=1183558958","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183558958?lang=en_us&edition=fundamental","pubTime":"2026-07-05 21:21","pubTimestamp":1783257672,"startTime":"0","endTime":"0","summary":"Global investors are reassessing the value of allocating funds to the Indian stock market. At a time when AI-driven trading continues to amplify volatility across global markets, India's market,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDE","INQQ","INDL","MEM","VTHR","PIN","QLVE","BK4585","IMVP","XCNY","RWEM","EMXC","INCO","ARTY","QTOC","PEMX","KEMX","CHAT","FLIN","IOPP","AIPO","INDA","XC","EEMA","XXCH","SEEM","STXE","NDIA","MFEM","AGIX","QEMM","AVEM","ASIA","BK4588","XSOE","EEMV","FEMR","HEEM","BKEM","DFAE","INDH","SCHE","SMIN","BBEM","BKF","EET","VEU","IND","SCIN","XCEM","BK4550","MEMX","BK4523","EQLT","EPI","DEXC","SPEM","NFTY","GLIN","INDY","BCHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161120576","title":"India's Stock Market Emerges as a Global Safe Haven Amid AI-Driven Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=1161120576","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161120576?lang=en_us&edition=fundamental","pubTime":"2026-07-05 19:51","pubTimestamp":1783252276,"startTime":"0","endTime":"0","summary":"India's stock market, with its low correlation to the artificial intelligence theme, is becoming a hedging tool for risk diversification within emerging market portfolios, transforming its perceived...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VEU","IND","MEM","SEEM","CHAT","BCHI","EMXC","AIPO","XCNY","INDA","XCEM","MEMX","NFTY","PIN","SPEM","VTHR","FLIN","HEEM","INDY","BK4523","NDIA","AGIX","IOPP","QEMM","SMIN","FEMR","INDH","ASIA","EQLT","XXCH","PEMX","MFEM","EET","DFAE","BKEM","GLIN","INCO","QLVE","XSOE","INQQ","INDE","ARTY","AVEM","BBEM","BKF","BK4585","EEMA","QTOC","DEXC","KEMX","RWEM","STXE","EPI","INDL","SCIN","BK4550","BK4588","EEMV","SCHE","XC","IMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138230472","title":"India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence","url":"https://stock-news.laohu8.com/highlight/detail?id=1138230472","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138230472?lang=en_us&edition=fundamental","pubTime":"2026-07-05 18:03","pubTimestamp":1783245823,"startTime":"0","endTime":"0","summary":"Global investors are reassessing the value of allocating to Indian equities. At a time when artificial intelligence trading continues to amplify volatility across global markets, the Indian market,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEEM","SCIN","ARTY","INDA","PIN","BBEM","INDH","MFEM","QEMM","INCO","INDE","INDL","NFTY","GLIN","EPI","XSOE","EQLT","INQQ","XC","VTHR","QTOC","XCNY","DFAE","IMVP","AGIX","EMXC","MEMX","FLIN","BK4550","FEMR","SPEM","EEMV","IOPP","QLVE","CHAT","BK4585","MEM","SEEM","BK4588","BKF","VEU","ASIA","BCHI","INDY","PEMX","SCHE","KEMX","BKEM","NDIA","AVEM","EET","AIPO","EEMA","XXCH","DEXC","STXE","SMIN","XCEM","RWEM","BK4523","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648695926","title":"India Ratings assigns and affirms IND BBB+ / A2 ratings to Foods & Inns bank facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648695926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648695926?lang=en_us&edition=fundamental","pubTime":"2026-07-03 21:03","pubTimestamp":1783083808,"startTime":"0","endTime":"0","summary":"The latest update is out from Foods & Inns Ltd. ( ($IN:FOODSIN) ). Foods & Inns Ltd. has announced that India Ratings & Research has reviewed and a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-assigns-and-affirms-ind-bbb-a2-ratings-to-foods-inns-bank-facilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-assigns-and-affirms-ind-bbb-a2-ratings-to-foods-inns-bank-facilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","BBB","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648684703","title":"Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2648684703","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648684703?lang=en_us&edition=fundamental","pubTime":"2026-07-03 01:05","pubTimestamp":1783011900,"startTime":"0","endTime":"0","summary":"Abbisko and AstraZeneca will jointly develop a Phase 1/2 NSCLC therapy combining lumipodlin with Tagrisso after China's IND clearance.","market":"sh","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/07/02/Doctor-Hand-Point-Patient-Lung-X-ray-Fil.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/07/02/Doctor-Hand-Point-Patient-Lung-X-ray-Fil.jpg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/07/60253296/abbisko-astrazeneca-team-up-on-lung-cancer-drug-combo-after-china-trial-clearance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/07/60253296/abbisko-astrazeneca-team-up-on-lung-cancer-drug-combo-after-china-trial-clearance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IND","BK4120","TISI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100428930","title":"Edding Genor Receives NMPA Approval for Phase Ib/II Clinical Trial of GB268","url":"https://stock-news.laohu8.com/highlight/detail?id=1100428930","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100428930?lang=en_us&edition=fundamental","pubTime":"2026-07-02 22:35","pubTimestamp":1783002933,"startTime":"0","endTime":"0","summary":"Edding Genor (06998) has announced that its Investigational New Drug application for the Phase Ib/II clinical trial of GB268, a highly differentiated and innovative PD-1/CTLA-4/VEGF trispecific...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IND","06998","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}